Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000435394 | SCV000513546 | likely benign | not specified | 2016-05-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000015395 | SCV001280932 | uncertain significance | Obesity | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Institute of Human Genetics, |
RCV001262822 | SCV001440830 | likely benign | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001699179 | SCV004297610 | uncertain significance | not provided | 2023-12-16 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 37 of the MC4R protein (p.Asp37Val). This variant is present in population databases (rs13447325, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features associated with MC4R-related obesity (PMID: 12970296). ClinVar contains an entry for this variant (Variation ID: 14319). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MC4R protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect MC4R function (PMID: 16752916). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000015395 | SCV000052812 | not provided | Obesity | 2015-10-02 | no assertion provided | clinical testing | |
Clinical Molecular Genetics Laboratory, |
RCV000015395 | SCV000692295 | uncertain significance | Obesity | 2017-11-22 | no assertion criteria provided | clinical testing | present with c.105C>A in two patients, phase not known |
Diagnostic Laboratory, |
RCV000015395 | SCV000733801 | likely benign | Obesity | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001699179 | SCV001924585 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001699179 | SCV001926982 | likely benign | not provided | no assertion criteria provided | clinical testing |